Biopharmaceuticals
Joao Duarte, MSc MPharm
Director, BPO Regulatory & Quality Affairs
Alexion, AstraZeneca Rare Disease
Peter W. Marks, MD, PhD
Director, Center for Biologics Evaluation and Research
United States Food and Drug Administration
Marco Cavaleri, PhD
Head of Biological Health Threats and Vaccine Strategy
European Medicines Agency
Amy Scott-Billman, MS
VP, Global Head Regulatory Affairs, Vaccines & Immune Therapies
AstraZeneca